Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell line

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3225-3231

  Köhler, Gabriele ^a   Veelken, Hendrik ^b   Rosenthal, Felicia ^b   Mackensen, Andreas ^b   Lindemann, Albrecht ^b   Schaefer, Hans Eckart ^a   Lahn, Michael ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

HSP 70; Oncogenes; Primary tumor cell culture; Renal cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR; HEAT SHOCK PROTEIN 70; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; ONCOGENE; ONCOGENE C FOS; ONCOGENE C MYC; ONCOGENE NEU; ONCOGENE RAS; PRIORITY JOURNAL; TUMOR CELL CULTURE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, CLEAR CELL; AGED; CARCINOMA, RENAL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MIDDLE AGED; ONCOGENES; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 1842291576     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends in Genetics 9: 138-141, 1993.
2. Harrington EA, Fanidi A, Evan GI: Oncogene and cell death. Current Opinion in Genetics and Development 4: 120-129, 1994.
3. Peter S: Oncogenes and growth factors in renal cell carcinoma. Urologia Internationalis 47: 199-202, 1991.
4. Nanus DM, Mentle IR, Motzer RJ, Bander NH, Albino AP: Infrequent ras oncogene point mutations in renal cell carcinoma. J Urology 143: 175-178, 1990.
5. Bot FJ, Godschalk JCJ, Krishnadath KK, Vanderkwast THM, Bosman FT: Prognostic factors in renal cell carcinoma -immunhistochemical detection of p53 protein versus clinicopathological parammeters. Int J Cancer 57: 634-637, 1994.
6. Imai Y, Strohmeyer TG, Fleischhacker M, Slamon DJ, Koeffler HP: p53 mutations and mdm-2 amplification in renal cell cancers. Modern Pathology 7: 766-770, 1994.
7. Uhlman DL, Nguyen PL, Manivel JC, Aeppli D, Resnick JM, Fraley EE, Zhang G, Nihans GA: Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 86: 1470-1475, 1994.
8. Efferth T, Volm M: Immuncytochemical detection of oncoproteins in animal and human tumor lines with acquired or inherent multidrug resistance. Cancer Detection Prevention 16: 237-243, 1992.
9. Rochlitz CF, Lobeck H, Peter S, Reuter J, Mohr B, de Kant E, Huhn D, Herrmann R: Multiple drug resistance gene expression in human renal cell cancer is associated with histologic subtype. Cancer 69: 2993-2998, 1991.
10. Volm M, Kästel M, Mattern J, Efferth T: Expression of resistance factors (p-glycoprotein, glutathione-S-transferase-pi, and topoisomerase II) and their interrelationship to protooncogene products in renal cell carcinoma. Cancer 71: 3981-3987, 1993.
11. Jäättelä M, Wissing D: Emerging role of heat shock proteins in biology and medicine. Annals Med 24: 249-258, 1992.
12. Lahn M, Köhler G, Schmoor C, Dengler W, Veelken H, Brennscheidt U, Mackensen A, Kulmburg P, Hentrich I, Jesuiter H, Rosenthal FM, Fiebig HH, Sommerkamp H, Farthmann EH, Hasse J, Mertelsmann R, Lindemann A: Processing of tumor tissues for vaccination with autologous tumor cells. Eur Surg Res 29: in press, 1997.
13. WHO: International Classification of Disease for Oncology. 2nd Edition. Editors: C Pearcy, V van Holten, C Muir. WHO-Press Geneva, 1990.
14. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedure. J Histochem Cytochem 29: 577-581, 1981.
15. Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R: Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha. Cancer Res 52: 3335-3339, 1992.
16. Lager DJ, Slagel DD, Palechek PL: The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma. Modern Pathology 7: 544-548, 1994.
17. Yoshida K, Tosaka A, Takeuchi S, Kobayashi N: Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 73: 1913-1918, 1994.
18. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM: Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 53: 3092-3097, 1993.
19. Davidoff AM, Igelhart JD, Marks JR: Immune response to p53 is dependent upon p53/HSP-70 complexes in breast cancer. Proc Natl Acad Sci USA 89: 3439-3442, 1992.
20. De Riese WT, Crabtree WN, Allhoff EP, Werner M, Liedke S, Lenis G, Atzpodien J, Kirchner H: Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma. J Clin Oncology 11: 1804-1808, 1993.
21. Lum BL, Gosland MP, Kaubisch DS, Sikic BI: Molecular Targets in Oncology: Implications of the multidrug resistance gene. Pharmacotherapy 13: 88-109, 1993.
22. Del Giudice G, Gervaix A, Costantino P, Wyler CA, Tougne C, De Graeff-Meeder E, Van Embden J, Van der Zee R, Nencioni L, Rappuoli R, Suter S, Lambert PH: Priming to Heat Shock proteins in infants vaccinated against pertussis. J Immunol 150: 2025-2032, 1993.
23. De Nagel DC, Pierce SK: A case for chaperones in antigen processing. Immunology Today 13: 86-89, 1992.
24. Srivastava PK, Maki RG: Stress-induced proteins in immune response to cancer. Current Topics in Microbiology and Immunology 167: 109-123, 1991.
25. Tamura Y, Tsuboi N, Sato N, Kikuchi K: 70 kDa Heat Shock Cognate protein is a transforamtion-associated antigen and a possible target for host's anti-tumor immunity. J Immunol 151: 5516-5524, 1993.
26. Udono H, Srivastava PK: Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178: 1391-1396, 1993.